Kimberly Manhard
Corporate Officer/Principal at ACADIA PHARMACEUTICALS INC.
Profile
Kimberly J.
Manhard is currently the Director at Shoreline Biosciences, Inc. and Toragen, Inc. She is also an Independent Director at Inhibrx Biosciences, Inc. and a Trustee at The Fleet Science Center.
In her former positions, she served as the Director & Corporate Compliance Officer at Ardea Biosciences, Inc. from 2009 to 2016.
She was also an Independent Director at Inhibrx, Inc. from 2020 to 2024.
Additionally, she held the position of Executive VP-Drug Development at Heron Therapeutics, Inc. in 2023.
Ms. Manhard has a background in Regulatory Affairs, having worked as the Head-Regulatory Affairs at Bristol Myers Squibb Co. and Agouron Global Commercial Operations.
She was also a Vice President-Regulatory Affairs at Exelixis, Inc. from 2002 to 2003.
Ms. Manhard holds an undergraduate degree from the University of Florida.
Kimberly Manhard active positions
| Companies | Position | Start |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 2024-01-29 |
| Fleet Science Center | Director/Board Member | - |
Shoreline Biosciences, Inc.
 Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Director/Board Member | 2021-05-18 |
Toragen, Inc.
 Toragen, Inc. BiotechnologyHealth Technology Toragen, Inc. is a clinical-stage biotechnology company that is focused on developing treatments for HPV-induced cancers, starting with head and neck cancer. Toragen is based in San Diego, CA. The company is targeting the root cause of virally induced cancers. The company was founded by Andrew Sharabi and the CEO is Sandra I. Coufal. | Director/Board Member | 2020-04-30 |
Former positions of Kimberly Manhard
| Companies | Position | End |
|---|---|---|
| INHIBRX, INC. | Director/Board Member | 2024-05-29 |
| HERON THERAPEUTICS, INC. | Director/Board Member | 2023-02-20 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Chief Operating Officer | 2009-06-22 |
| EXELIXIS, INC. | General Counsel | 2002-12-31 |
| G.H. Besselaar Associates | Corporate Officer/Principal | - |
Training of Kimberly Manhard
| University of Florida | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| HERON THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| INHIBRX, INC. | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Private companies | 6 |
|---|---|
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
| Agouron Global Commercial Operations | |
| G.H. Besselaar Associates | |
| Fleet Science Center | |
Shoreline Biosciences, Inc.
Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Health Technology |
Toragen, Inc.
Toragen, Inc. BiotechnologyHealth Technology Toragen, Inc. is a clinical-stage biotechnology company that is focused on developing treatments for HPV-induced cancers, starting with head and neck cancer. Toragen is based in San Diego, CA. The company is targeting the root cause of virally induced cancers. The company was founded by Andrew Sharabi and the CEO is Sandra I. Coufal. | Health Technology |
- Stock Market
- Insiders
- Kimberly Manhard
